Medication info
Korea Candesartan Plus Tablets (Candesartan Cilexetil, Hydrochlorothiazide)

Korea Candesartan Plus Tablets (Candesartan Cilexetil, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Korea Pharmaceutical Co., Ltd.
Appearance
Biconvex, pale pink, rectangular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200904344 · Notified 2009.06.22 · Insurance code 642801980

Summary

Main use
Treatment of essential hypertension inadequately controlled with treatment using the individual components
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dosage adjustment of this medicine is necessary for elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective circulating blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with treatment using the individual components

  • Essential hypertension
View approved original text

This medicine is used for patients with essential hypertension where treatment with individual components alone is insufficient. This medication effectively lowers blood pressure, thereby reducing the burden on the heart and blood vessels. Therefore, it helps manage hypertension and contributes to reducing the risk of cardiovascular complications.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dosage adjustment of this medicine is necessary for elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective circulating blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Do not take this medication if you have an allergic reaction to any of its components or if you have specific kidney and liver diseases, gout, electrolyte imbalance, etc. Patients with excessively low blood pressure or issues with fluid and electrolyte balance, patients with liver disease at risk of hepatic coma, and patients with heart valve disease should use this medication with caution. The Hydrochlorothiazide component may make the skin sensitive to sunlight, so it is important to limit sun exposure and take protective measures to reduce the risk of skin cancer. This medication has a blood pressure-lowering effect, which may cause side effects such as dizziness, headaches, nausea, and fatigue. If these symptoms are severe, consult a physician. While taking this medication, regular blood tests to monitor electrolytes, kidney function, liver function, etc., should be performed, paying particular attention to changes in potassium levels. When taking this medication in conjunction with other antihypertensives, diuretics, potassium supplements, non-steroidal anti-inflammatory drugs, etc., it is essential to inform healthcare professionals due to the potential for interactions. This medication is not recommended for breastfeeding women; if necessary, breastfeeding should be discontinued. Safety in children or adolescents under the age of 18 has not been established, so caution is advised. Elderly patients may have weakened heart and kidney function; therefore, closer monitoring is required when using this medication. In case of overdose, symptoms such as hypotension, dizziness, and electrolyte imbalance may occur, prompting an immediate visit to a medical institution for appropriate treatment. This medication should be kept out of the reach of children and stored in its original container to maintain quality and prevent misuse. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur.

Side effects

  • Headache
  • back pain
  • dizziness
  • respiratory tract infection
  • symptoms similar to epidemic cold
  • sinusitis
  • bronchitis
  • urinary tract infection
  • nausea
  • contusion
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • rhinopharyngitis
  • cough
  • elevated blood sugar
  • increased serum uric acid
  • elevated ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • elevated urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • dizziness
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • increased liver enzyme levels
  • abnormal liver function
  • hepatitis
  • cardiac arrhythmia
  • sensory disturbances
  • transient visual blurring
  • choroidal effusion
  • acute myopia
  • acute closed-angle glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • loss of appetite
  • appetite loss
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • skin erythematosus lupus-like reaction
  • activation of skin erythematosus lupus
  • muscle spasms
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylaxis reaction
  • jaundice
  • sleep disorders
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • otalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a well-sealed container to prevent air or moisture ingress, preferably in a cool place at or below 30 degrees Celsius. Proper storage can maintain the drug's efficacy for an extended period.

Appearance and packaging

Appearance

Biconvex, pale pink, rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.